BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37971651)

  • 1. Incidence, severity, and temporal development of oral complications in pediatric allogeneic hematopoietic stem cell transplant patients - a multicenter study.
    Agholme MB; Dahllöf G; Törlén JK; Majorana A; Brennan MT; von Bültzingslöwen I; Tan PL; Hu S; Sim YF; Hong C
    Support Care Cancer; 2023 Nov; 31(12):702. PubMed ID: 37971651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Oral Side Effects from Conditioning Therapy Before Hematopoietic Stem Cell Transplantation: Protocol for a Multicenter Study.
    Brennan MT; Hasséus B; Hovan AJ; Raber-Durlacher JE; Blijlevens NM; Huysmans MC; Garming Legert K; Johansson JE; Moore CG; von Bültzingslöwen I
    JMIR Res Protoc; 2018 Apr; 7(4):e103. PubMed ID: 29685874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
    Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary study in a new protocol for the treatment of oral mucositis in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) and chemotherapy (CT).
    Vitale MC; Modaffari C; Decembrino N; Zhou FX; Zecca M; Defabianis P
    Lasers Med Sci; 2017 Aug; 32(6):1423-1428. PubMed ID: 28664389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of oral mucositis in allogeneic hematopoietic stem cell transplantation between conventional and reduced-intensity regimens.
    Kashiwazaki H; Matsushita T; Sugita J; Shigematsu A; Kasashi K; Yamazaki Y; Kanehira T; Kondo T; Endo T; Tanaka J; Hashino S; Nishio M; Imamura M; Kitagawa Y; Inoue N
    Support Care Cancer; 2012 May; 20(5):933-9. PubMed ID: 21494780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of severe oral mucositis in patients undergoing different conditioning regimens in haematopoietic stem cell transplantation.
    Nakagaki M; Kennedy GA; Gavin NC; Clavarino A; Whitfield K
    Support Care Cancer; 2022 Nov; 30(11):9141-9149. PubMed ID: 36008731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral mucositis in paediatric cancer patients undergoing allogeneic hematopoietic stem cell transplantation preventively treated with professional dental care and photobiomodulation: Incidence and risk factors.
    Miranda-Silva W; da Fonseca FP; Gomes AA; Mafra ABB; Rocha V; Fregnani ER
    Int J Paediatr Dent; 2022 Mar; 32(2):251-263. PubMed ID: 34115428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell transplantation patients receiving a novel oral care protocol for oral mucositis prevention and treatment: patient-reported outcomes and quality of life.
    Guberti M; Botti S; Fusco A; Caffarri C; Cavuto S; Savoldi L; Serra N; Merli F; Piredda M; De Marinis MG
    Support Care Cancer; 2022 Jul; 30(7):6317-6325. PubMed ID: 35474550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting.
    Stiff PJ; Emmanouilides C; Bensinger WI; Gentile T; Blazar B; Shea TC; Lu J; Isitt J; Cesano A; Spielberger R
    J Clin Oncol; 2006 Nov; 24(33):5186-93. PubMed ID: 16391299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral mucositis-related oropharyngeal pain and correlative tumor necrosis factor-alpha expression in adult oncology patients undergoing hematopoietic stem cell transplantation.
    Fall-Dickson JM; Ramsay ES; Castro K; Woltz P; Sportés C
    Clin Ther; 2007; 29 Suppl():2547-61. PubMed ID: 18164921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation.
    Nguyen DT; Shayani S; Palmer J; Dagis A; Forman SJ; Epstein J; Spielberger R
    Support Care Cancer; 2015 Nov; 23(11):3141-7. PubMed ID: 25791390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral status of patients submitted to autologous hematopoietic stem cell transplantation.
    Fernandes LL; Torres SR; Garnica M; de Souza Gonçalves L; Junior AS; de Vasconcellos ÁC; Cavalcanti W; Maiolino A; de Barros Torres MC
    Support Care Cancer; 2014 Jan; 22(1):15-21. PubMed ID: 23975228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trial.
    Kamsvåg T; Svanberg A; Legert KG; Arvidson J; von Essen L; Mellgren K; Toporski J; Winiarski J; Ljungman G
    Support Care Cancer; 2020 Oct; 28(10):4869-4879. PubMed ID: 31993753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Effect of Polaprezinc, a Zinc-L-carnosine, Against Chemotherapy-induced Oral Mucositis in Pediatric Patients Undergoing Autologous Stem Cell Transplantation.
    Funato M; Ozeki M; Suzuki A; Ishihara M; Kobayashi R; Nozawa A; Yasue S; Endo-Ohnishi S; Fukao T; Itoh Y
    Anticancer Res; 2018 Aug; 38(8):4691-4697. PubMed ID: 30061237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral health and hematopoietic stem cell transplantation: A longitudinal evaluation of the first 28 days.
    Doss LM; Dandoy CE; Kramer K; Pate A; Flesch L; El-Bietar J; Lane A; Davies SM; Thikkurissy S
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28843053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens.
    Cutler C; Li S; Kim HT; Laglenne P; Szeto KC; Hoffmeister L; Harrison MJ; Ho V; Alyea E; Lee SJ; Soiffer R; Sonis S; Antin JH
    Biol Blood Marrow Transplant; 2005 May; 11(5):383-8. PubMed ID: 15846292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral cryotherapy for oral mucositis management in patients receiving allogeneic hematopoietic stem cell transplantation: a prospective randomized study.
    Lu Y; Zhu X; Ma Q; Wang J; Jiang P; Teng S; Zhou L; Wu D; Wang H
    Support Care Cancer; 2020 Apr; 28(4):1747-1754. PubMed ID: 31302767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral health as a predictive factor for oral mucositis.
    Coracin FL; Santos PS; Gallottini MH; Saboya R; Musqueira PT; Barban A; Chamone Dde A; Dulley FL; Nunes FD
    Clinics (Sao Paulo); 2013 Jun; 68(6):792-6. PubMed ID: 23778491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral complaints and dental care of haematopoietic stem cell transplant patients: a qualitative survey of patients and their dentists.
    Bos-den Braber J; Potting CM; Bronkhorst EM; Huysmans MC; Blijlevens NM
    Support Care Cancer; 2015 Jan; 23(1):13-9. PubMed ID: 24908427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Markiewicz M; Dzierzak-Mietla M; Frankiewicz A; Zielinska P; Koclega A; Kruszelnicka M; Kyrcz-Krzemien S
    Support Care Cancer; 2012 Sep; 20(9):2223-9. PubMed ID: 22736463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.